Hideyuki Kanno

Discovery of N-[(1R,2S,5S)-2-{[(5-chloroindol-2-yl)carbonyl]amino}-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide hydrochloride: A novel, potent and orally active direct inhibitor of factor Xa

Tsutomu Nagata, Toshiharu Yoshino, Noriyasu Haginoya et al. · Bioorganic & Medicinal Chemistry · 2008 · 42 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +11

Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors

Tsutomu Nagata, Toshiharu Yoshino, Noriyasu Haginoya et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 33 citations · Full text

Medicinal Chemistry, Medicine, Cycloalkanediamine Derivatives +6

Thromboxane A2 synthetase inhibitors. 2. Syntheses and activities of tetrahydronaphthalene and indane derivatives

M. KANAO, Yoshifumi Watanabe, Youichi Kimura et al. · Journal of Medicinal Chemistry · 1989 · 31 citations

Synthesis and Antiallergy Activity of (1,3,4)Thiadiazolo(3,2-a)-1,2,3-triazolo(4,5-d)pyrimidin-9(3H)-one Derivatives. I.

Norio Suzuki, Hideyuki Kanno, Hideo Takamori et al. · Chemical and Pharmaceutical Bulletin · 1992 · 28 citations · Full text

Ring Closure, Medicinal Chemistry, Derivative (Chemistry) +12

New synthesis of (.+-.)-emetine from tetrahydroprotoberberine precursors via an .alpha.-diketone monothioketal intermediate

Seiichi Takano, Makoto Sasaki, Hideyuki Kanno et al. · The Journal of Organic Chemistry · 1978 · 24 citations

Combinatorial Chemistry, Bioorganic Chemistry, Engineering +16